GLENMARK PHARMACEUTICALS
Back to Balance Sheet
|
GLENMARK PHARMACEUTICALS Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹3,328 Cr | ₹1,609 Cr | ₹3,877 Cr | ₹3,593 Cr | ₹3,159 Cr |
What is the latest Net Current Assets ratio of GLENMARK PHARMACEUTICALS ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹3,328 Cr |
| Mar2024 | ₹1,609 Cr |
| Mar2023 | ₹3,877 Cr |
| Mar2022 | ₹3,593 Cr |
| Mar2021 | ₹3,159 Cr |
How is Net Current Assets of GLENMARK PHARMACEUTICALS Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹3,328 Cr | 106.80 | |
| Mar2024 | ₹1,609 Cr | -58.49 | |
| Mar2023 | ₹3,877 Cr | 7.92 | |
| Mar2022 | ₹3,593 Cr | 13.75 | |
| Mar2021 | ₹3,159 Cr | - | |
Compare Net Current Assets of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹62,881.2 Cr | 9.2% | 15.2% | 58.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹434,999.0 Cr | 3.6% | 7% | 15.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,139.0 Cr | 1.1% | 5.8% | 14.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,791.0 Cr | 1.9% | 12.3% | 49.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,664.0 Cr | 1.8% | 5.9% | 14.8% | Stock Analytics | |
| CIPLA | ₹107,685.0 Cr | 1.6% | 0.2% | -5.4% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | 9.2% |
15.2% |
58.8% |
| SENSEX | -2.5% |
-6.1% |
7% |
You may also like the below Video Courses